Article
Analysis of long-term persistence of resistance mutations within the hepatitis C virus NS3 protease after treatment with telaprevir or boceprevir.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 1 Dec 2011
Susser Simone, Vermehren Johannes, Forestier Nicole, Welker Martin Walter, Grigorian Natalia, Füller Caterina, Perner Dany, Zeuzem Stefan, Sarrazin Christoph
Abstract excerpt
BACKGROUND: Telaprevir and boceprevir are highly selective hepatitis C virus (HCV) NS3/4A proteaseinhibitors in phase 3 development. Viral breakthrough during mono- and triple-therapies with PEG-interferon and ribavirin and relapse is associated with resistance. OBJECTIVES: Potential persistence of resistance mutations during long-term follow-up should be analyzed. STUDY DESIGN: Clonal sequence analysis of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
